This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Emergent BioSolutions Management Presents At JPMorgan SMid Cap Conference (Transcript)

Emergent BioSolutions Inc. ( EBS)

JPMorgan SMid Cap Conference

November 30, 2011 8:45 a.m. ET

Executives

R. Don Elsey - CFO

W. James Jackson - SVP and Chief Scientific Officer

Analysts

Cory Kasimov - JPMorgan

Presentation

Cory Kasimov

Hi. Good morning, everybody. My name's Cory Kasimov. I'm the Senior Biotechnology analyst at JPMorgan. It's my pleasure to welcome you to our annual SMid Cap Conference. And furthermore, it's my pleasure to introduce our first company to present today, which is Emergent BioSolutions. Giving the presentation will be their company's Chief Financial Officer, Don Elsey. We also have Jim Jackson and Bob Burrows from the company sitting up here as well.

And following Don's presentation, we will have a Q&A session right here in this room. So, with that I will turn it over to Don.

R. Don Elsey

Thank you, Cory. I would welcome, everybody, to the first presentation of the day. We got you up early. And I do want to say Emergent is the most successful biotechnology that is at this SMid Conference this week. Of course, we're the only biotech company. So – and we do have a lot of competition in that I understand Tupperware is presenting a couple of doors down and so they put a lid on it. I just couldn't resist. I'm sorry.

All right. So now that we got that out of the way, as Cory is like going, why did I invite these guys. We'll start with the obligatory forward-looking. We're going to make some forward-looking comments and actual results may differ. Let's move on.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs